Top

Reactions Weekly

Published in:

01-05-2023 | Chronic Lymphocytic Leukemia | Case report

Antineoplastics

Chronic lymphocytic leukemia, lack of efficacy and off label use: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Burgess M, et al. Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic Leukemia. Acta Haematologica 146: 166-171, No. 2, Jan 2023. Available from: URL: http://doi.org/10.1159/000527631

Title: Antineoplastics
Chronic lymphocytic leukemia, lack of efficacy and off label use: case report
Publication date: 01-05-2023
Publisher: Springer International Publishing
Keywords: Chronic Lymphocytic Leukemia
Neck and Back Pain
Melanoma
Melanoma
Ibrutinib
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-38285-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antineoplastics

Chronic lymphocytic leukemia, lack of efficacy and off label use: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Methotrexate

Azd-1222/tozinameran

Multiple drugs

Heparin

Dasatinib/nilotinib

Convalescent-anti-SARS-CoV-2-plasma